Biotech startup Immusoft raises $3 million and hires new CEO

The first chunk of Immusoft's ongoing Series B round will help new CEO Sean Ainsworth move its gene therapy into human clinical trials.

Source: bizjournals.com Health Care:Physician Practices headlines - January 9, 2018 Category: American Health Authors: Casey Coombs Source Type: news